Health Condition 1: L209- Atopic dermatitis, unspecified
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1.Patient with known case of atopic dermatitis along with specific symptomatology of atopic dermatitis according to criteria of American academy dermatology of eczema with increased IgE level . 2.Patient of Age group 18-60 years of either sex.
Exclusion criteria
Exclusion criteria: 1.Patients who are contraindicated for virechana karma- like lower GI bleeding, Prolapse of rectum, incontinence of stool etc. will not be included in the trial group 2. Patients of other skin disorders (like psoriasis,seborrheic dermatitis ,scabies,contact dermatitis,lupus erythematous etc.) . 3. Patients with comorbid condition such as Diabetes mellitus(having HbA1c greater than 7.5 percent with or without antihyperglycemic medication). 4. Patients with renal or hepatic impairment (Sr. creatinine greater than 1.8 mg/dl, SGOT and SGPT greater than Five times of upper limit . 5. Patients who are taking immunomodulatory drug since last 2 month, antitubercular ,anti-retroviral drugs,steroids,antibiotics, etc . 6. Patients requiring emergency treatment
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Proportion of patients showing mean reduction in Sr. IgE levelTimepoint: Proportion of Patients showing mean reduction in Sr. IgE level,7days After completion of trial | — |
Secondary
| Measure | Time frame |
|---|---|
| Proportion of patients showing mean reduction in Srhistamine level and cytokine profile (IL4,IL13) from baseline to 29 days • Proportion of patients showing mean reduction in subjective criteria like SCORAD score,DLQI, EASI,ItchNRS Scale from baseline to 29 days.Timepoint: 0 to 29 days | — |
Countries
India
Contacts
Ayuvedic and unani Tibbia College and Hospital, Karol Bagh, New Delhi